Last night marked a new historical event for Perrier-Jouët champagne House, with the international unveiling of Perrier-Jouët Belle Epoque Florale Edition by Makoto Azuma – the first designed Limited Edition of cuvee Belle Epoque, since the creation of its iconic anemones by Emile Gallé in 1902. The launch event took place in Japan, which has a strong historical relationship with the luxury house.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56570-champagne-perrier-jouet
This year marks the 10th anniversary of the “Big Four” of 2004, when, for the first time in recorded history, four hurricanes struck the Florida coast in one year. Charley, Frances, Ivan, and Jeanne caused an estimated $45 billion in damage, the costliest U.S. Atlantic hurricane season on record at that time.
Flooding is the Nation’s costliest and deadliest natural disaster, affecting every state in the United States. According to the National Hurricane Center (NHC), storm surge poses the greatest threat to life and property along U.S. coasts.
Dr. Rick Knabb, director of the NHC, stated, “Hurricanes and flooding can pose serious risks to your family and property. By making a plan and taking preventive actions, you can get ahead of the storm and protect what matters to you.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7249151-national-hurricane-center-flash-flood-preparedness-2014-hurricane-season/
Join P&G and the Children’s Safe Drinking Water Program (CSDW) to provide clean drinking water to children in need.
GIVE HEALTH partners with the non-profit P&G Children’s Safe Drinking Water Program (CSDW) to provide PUR packets in developing countries. These packets, developed by P&G and the U.S. Centers for Disease Control, use some of the same ingredients as municipal water systems to remove pollutants from contaminated water. Since 2004, CSDW has provided more than 3 billion liters of water to children in need in over 60 countries.
To view Multimedia News Release, go to http://www.multivu.com/players/English/49448-PG-myGive-Campaign/
Me at the organ of Ombersley Road Methodist Church in Barbourne, Worcester where I was organist at during 2004 and 2005 before moving to Manchester. Im playing the hymn
Cathay Che is a New York based travel writer who has blazed her way through about 50 countries (so far). She is also the author of the book, Deborah Harry: Platinum Blonde, the only authorized biography of the iconic Blondie frontwoman. She was a contributing editor at Time Out New York from 1995-2004, and is now a contributing editor at LEXUS magazine. She has been happily contributing her uncensored travel blog, TRAVEL JUNKIE: Addicted to a Taste of Strange, to MOLI.com for sixteen months. She has also written for concierge.com, DailyCandy.com, Brides, forbestraveler.com, Everyday With Rachel Ray, Budget Travel, Mens Journal, Details, Interview, InStyle, The New York Post travel section, The Honolulu Advertiser, men.style.com, and Glamour. As a performance artist, Che has appeared in New York at The Kitchen, PS 122, Dixon Place, WOW Cafe, Exit Art and The Public Theater. Her first media-related job was as the on-air movie reviewer for the cable TV show, Party Talk, from 1993-1996. Courtesy of cathayche on MOLI.com.
Visit cathayche in the MOLI View
ature Reviews Genetics (NRG) and Arkitek today jointly announce the launch of a new version of the popular RNA interference animation originally launched on NRG’s site in 2004. Arkitek and Nature Reviews Genetics decided to update the RNAi animation to showcase the new information learned about the functions of small RNAs.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53855-nature-reviews-genetics-and-arkitek-announce-rna-interference-animation
InSightec Ltd, the leader in magnetic resonance imaging (MRI)-guided Focused Ultrasound therapy, announced that the U.S. Food and Drug Administration (FDA) has approved ExAblate® MRI-guided focused ultrasound as a therapy to treat pain from bone metastases in patients who do not respond or cannot undergo radiation treatment for their pain. This is the second FDA approval for ExAblate, which has been used widely since it was approved in 2004 as a non-invasive, outpatient, therapy for uterine fibroids.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56632-insightec-fda-approves-exablate
